{"id":"ai-assisted-insulin-system","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Device malfunction or software error"}]},"_chembl":{"chemblId":"CHEMBL1201631","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This system uses machine learning algorithms to process continuous glucose monitoring data, patient behavior patterns, and physiological parameters to provide personalized insulin dosing recommendations. It aims to reduce hypoglycemic episodes and improve overall glucose management by predicting glucose trends and adjusting insulin delivery accordingly, functioning as a decision-support tool for insulin therapy optimization.","oneSentence":"An artificial intelligence-assisted system that optimizes insulin dosing and delivery by analyzing real-time glucose data and patient factors to improve glycemic control.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:20:29.679Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus requiring insulin therapy"}]},"trialDetails":[{"nctId":"NCT07304778","phase":"NA","title":"Evaluation of a Mobile AI-powered Decision Support System for Insulin Dosing and Glucose Prediction in Type 1 Diabetes: The glUCModel Clinical Trial Protocol","status":"RECRUITING","sponsor":"Universidad Complutense de Madrid","startDate":"2025-07-11","conditions":"Diabetes (Insulin-requiring, Type 1 or Type 2)","enrollment":34},{"nctId":"NCT06319300","phase":"NA","title":"Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2024-04-19","conditions":"Diabetes Type 2","enrollment":140},{"nctId":"NCT06434584","phase":"","title":"Explainable Insulin Decision-making System to Assist Physicians in Diabetes Management","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2022-12-10","conditions":"Diabetes","enrollment":48},{"nctId":"NCT04642378","phase":"NA","title":"Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus Patients","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-10-01","conditions":"Type 2 Diabetes","enrollment":149},{"nctId":"NCT05231174","phase":"NA","title":"Efficacy of Using Large Language Model to Assist in Diabetic Retinopathy Detection","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2023-05-01","conditions":"Diagnosis, Diabetic Retinopathy","enrollment":535},{"nctId":"NCT04517201","phase":"NA","title":"AI-Assisted Insulin Titration System on Inpatients Glucose Control","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2020-11-04","conditions":"Type 2 Diabetes","enrollment":120},{"nctId":"NCT04053959","phase":"PHASE4","title":"Artificial Intelligence Assisted Insulin Titration System","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2019-09-27","conditions":"Type 2 Diabetes","enrollment":46}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"AI assisted insulin system","genericName":"AI assisted insulin system","companyName":"Shanghai Zhongshan Hospital","companyId":"shanghai-zhongshan-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"An artificial intelligence-assisted system that optimizes insulin dosing and delivery by analyzing real-time glucose data and patient factors to improve glycemic control in diabetes management. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus requiring insulin therapy.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}